BrightSpring Q2 revenue $3.15B (+29% YoY); Adj. EBITDA $143M (+29%); raises FY2025 guidance

BrightSpring Health Services, Inc.

2025-Q2 EPS reported $0.27 revenue$6,025,827,000

Net revenue $3,148M (+29.1% YoY); net income from cont. ops $8.5M (flat YoY).
Adjusted EBITDA $143M (+28.8%); Pharmacy Solutions segment EBITDA $125M (+32%).
Full-year 2025 guidance raised: revenue $12.2-12.6B, Adj. EBITDA $590-605M.
Divestiture of Community Living to Sevita on track for Q4 2025.
CEO cites strong performance across Pharmacy and Provider segments.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.